TABLE 2.
Differently Expressed miRNAs in the Plasma of CASH vs non-CASH Subjects
| miRNA | Log2 (fold change) | P value | P value (FDR corrected) |
|---|---|---|---|
| hsa-miR-363-3p | 4.275 | .000 | .003 |
| hsa-miR-486-5p | 2.900 | .000 | .003 |
| hsa-miR-15a-5p | 3.490 | .000 | .003 |
| hsa-miR-25-3p | 2.704 | .000 | .003 |
| hsa-miR-106b-3p | 2.975 | .000 | .006 |
| hsa-miR-16-2-3p | 5.263 | .000 | .007 |
| hsa-miR-183-5p | 2.985 | .000 | .007 |
| hsa-miR-16-5p | 2.426 | .000 | .007 |
| hsa-miR-185-5p | 2.813 | .000 | .012 |
| hsa-miR-501-3p | 1.923 | .001 | .032 |
| hsa-miR-181a-5p | 1.183 | .002 | .036 |
| hsa-miR-532-5p | 5.468 | .002 | .036 |
| hsa-mir-7641-2-3p_novel | 7.484 | .002 | .037 |
False discovery rate, FDR
Republished with permission of American Society for Clinical Investigation, from JCI Insight, Biomarkers of CASH, Lyne et al, 4(12), 201941; permission conveyed through Copyright Clearance Center, Inc.